Who we are
M&S Decisions is a scientific consulting company founded in May 2015. We use modeling methods to support decision-making in drug development.
Our services
We provide services for pharma and biomedical companies. We have expertise in translational science, quantitative systems pharmacology, population modeling, biostatistics and post-marketing research.
Our Team
Our scientists have over 15 years of experience in R&D projects for global pharmaceutical companies.
7
years
our company provides scientific consulting services to the clients worldwide.
8
regulatory agencies
regulatory agencies accepted our simulation reports and registration dossiers.
100
scientific articles
have been published in highly cited peer-reviewed journals.
The latest news
Our experience
Techniques
- Population PKPD and Exposure-Response
- Quantitative Systems Pharmacology
- Physiologically based PK/PBPK
- Systems Biology
- Biostatistics and Data Science
- Model-Based Meta-Analyses
- Bayesian modeling
- Artificial Intelligence & Machine Learning
- Health Economics & Real-World Evidence
- Software Development
Disease Areas
- Oncology including Immuno-Oncology
- Cardiovascular & Metabolic Diseases
- Respiratory Diseases
- Neurological Diseases
- Auto-Immune Diseases
- Ophthalmic Diseases
Therapeutic Modalities
- Small molecules
- Engineered proteins: antibodies, bi/tri-specifics, antibody-drug conjugates
- RNA-based modalities including antisense nucleotides and siRNA’s
- Gene- & cell-based therapies
